Tiger BufordYour Orthopedic Industry Expert (free today)

The economic benefit of health providers who use TracPatch - BoneChat #64 short

24 Feb 2025 · 2 min

Watch on YouTube

1:42

In this short, the speaker explains that the primary value of TracPatch lies in its convenience and economic impact rather than direct clinical outcome improvements. Early gains in knee flexion (e.g., achieving 3° earlier) are framed as modest and not clinically significant, but they can help ambulatory surgery centers (ASCs) facing reduced reimbursements and bundled payment pressures by boosting revenue. For patients, the device reduces travel needs, lowers out‑of‑pocket copays, and improves overall quality of life. The speaker also mentions an ongoing collaboration with the University of Miami to analyze social determinants of health among TracPatch users, noting that 60% of the cohort is Hispanic and 50% have obesity class 2 or higher. Findings show comparable passive compliance (simply wearing the device) across demographic groups, and surprisingly high active compliance (exercise participation) among 70‑year‑old Spanish‑speaking women living alone, matching that of typical domestic users.

Chapters

basically if you're in an ideal state. The question is, is that if I could get to 3 degrees of flexion 2 days earlier or 10 days earlier, is that valuable? And to me, the answer is not really. And so it's— what it is, is it becomes a convenience factor and an economic value because, A, if you're getting economically squeezed with decreased reimbursements and you're being forced into bundles, you need to be able to work as an organization, particularly if you're an ASC, where you're continually getting cut. On the other side though, there's a substantial benefit for patients that don't— that if they have travel restrictions or other things, their quality of life is much higher because they can do most of what they need to, and they also save money because they're not paying on their copays. So it's a— so we're using the technology not necessarily to improve outcomes, but to improve quality of life and to increase revenue generation for clinics and organizations. So one of the other things that we're doing right now is we're working with the University of Miami to publish a, a social determinants of health analysis. 60% is Hispanic and then 50% is class 2 obesity or higher. And what we're seeing is that both of what we call passive compliance. So are they just wearing the devices each day? Is there's no difference between the groups. And then, uh, active compliance— are they doing exercise and stuff? So we have these 70-year-old Spanish-speaking ladies living at home by themselves that are just as compliant as, you know, the standard domestic.